What Is Semax + Selank? Research Overview of the Neuropeptide Combination

Overview

Semax and Selank are two distinct, individually-characterized synthetic peptides originating from Russian pharmacological research. They are sometimes studied together as a combination in preclinical research settings because both are investigated within the broader domain of neuropeptide signaling, though they act through different proposed mechanisms and derive from different parent molecules. Unlike undisclosed proprietary blends, this combination pairs two well-defined, separately documented compounds: Semax, a heptapeptide analog of ACTH(4-10), and Selank, a synthetic analog of the endogenous tetrapeptide tuftsin. This article summarizes publicly available research context on each peptide individually. It is intended for laboratory and educational purposes only.

Semax: Structure & Research Mechanism

Semax is a synthetic heptapeptide derived by modifying a fragment of adrenocorticotropic hormone, ACTH(4-10), with the addition of a short C-terminal sequence (Pro-Gly-Pro) intended to enhance metabolic stability relative to the native fragment. It lacks the hormonal (corticotropic) activity of full ACTH. In animal model research, Semax has been studied for its association with brain-derived neurotrophic factor (BDNF) expression and broader neurotrophic signaling pathways. Investigators have used Semax as a research tool to probe mechanisms of neuroplasticity, neuronal survival signaling, and central nervous system response to ischemic or stress-related challenge in laboratory animal models. Ongoing academic interest centers on how modulation of ACTH-derived peptide fragments may intersect with neurotrophin regulation at the molecular level.

Selank: Structure & Research Mechanism

Selank is a synthetic analog of tuftsin, an endogenous tetrapeptide, extended with an additional short peptide sequence (Pro-Gly-Pro) to improve enzymatic stability. In preclinical literature, Selank has been investigated for its association with GABAergic and serotonergic signaling systems in rodent models, as well as for potential immunomodulatory research applications linked to its tuftsin-derived structure. Researchers have examined Selank in the context of stress-response paradigms and neurochemical assays measuring monoamine and GABA-related markers, using it as a molecular probe for these signaling pathways rather than as a therapeutic agent. As with Semax, findings are confined to animal model and in vitro research and have not been established in human clinical contexts through this supplier.

Research Considerations

Peptides intended for laboratory research should be stored lyophilized at manufacturer-recommended low temperatures, shielded from light and moisture, to preserve structural integrity prior to any research use. Verification of purity and identity through third-party analytical methods (such as HPLC and mass spectrometry) is a standard practice for research-grade material. Researchers should follow their institution's standard laboratory handling protocols, including appropriate personal protective equipment and containment procedures, when working with any peptide compound. This section addresses storage and handling only and does not constitute or imply guidance for administration, dosing, or use in humans or animals outside of authorized research settings.

Preclinical Research Summary

Across the existing preclinical literature, Semax and Selank are each characterized as regulatory peptides with distinct proposed mechanisms: Semax's research profile centers on neurotrophic factor signaling and neuroplasticity-related pathways, while Selank's research profile centers on GABAergic/serotonergic modulation and immune-peptide activity. Because they are studied via separate biochemical pathways, some researchers investigate them in combination to explore potential overlapping or complementary effects on neurological signaling networks in animal models. This remains an area of ongoing academic inquiry, and findings from animal studies should not be extrapolated to human outcomes.

Research Use Only

This product combination is offered strictly for in vitro laboratory and preclinical research use. It is not listed for sale on this site and is currently pending analytical testing and certificate of analysis (COA) verification. This peptide combination is not a drug, dietary supplement, or cosmetic, and is not intended for human or veterinary use, diagnosis, treatment, cure, or prevention of any disease. All information presented here is for educational purposes to support the research community and should not be interpreted as a recommendation for use outside of a controlled, authorized research environment.